Page 393 - Reuters%20/undefined

State Bank of India plans to raise up to $3 billion via debt in FY25

Several state run-lenders, including Canara Bank, Punjab and Sind Bank and Punjab National Bank , plan to raise funds via debt this fiscal year

Rise in Britain's jobless rate muddies PM Sunak's message to voters

Official data on Tuesday showed the jobless rate for the three months to April rose to 4.4 per cent from 4.3 per cent

China's Premier Li Qiang to visit Australia this week, says PM Albanese

China is Australia's largest trading partner, with Australian resources and energy exports dominating trade flow

Indian firms increased forex hedging in volatile election-results week

Importers bought foreign exchange forward contracts worth $9 billion last week, a more than 70 per cent jump from the same period a year before

RBI must review plan to raise provisions against infra loans: Lobby group

Last month, the Reserve Bank of India (RBI) proposed that banks and non-banking financial companies set aside a provision of 5 per cent of the total loan amount of infrastructure projects

India's proposed EU-like antitrust law to pose new challenge for tech firms

Apple, Google, Meta, Amazon would come under the purview of the Indian law, which has yet to be approved by parliament

UBS, Credit Suisse's Swiss units may merge by July 1, says official

UBS, which acquired its former rival Credit Suisse last year after the bank's collapse, had previously indicated the two units would be combined

Rupee remains stable, volatility expectations drop as RBI maintains grip

The rupee remained in a narrow band on Monday, with likely intervention from the RBI limiting weakness in the currency, traders said

Modi govt plans to stick to deficit target despite Lok Sabha poll setback

Rating agencies and analysts have said the government may step up welfare spending as well as support for states represented by partners in the National Democratic Alliance

HSBC adds more than 300 to China's headcount after Citi wealth acquisition

The portfolio acquisition demonstrates HSBC's commitment to the Chinese market

Asia stocks trade in narrow range as European politics adds new risks

S&P 500 futures and Nasdaq futures both eased 0.1 per cent in Asian trading, after edging higher on Monday

Govt bond yields little changed ahead of US inflation data, Fed meet

India consumer inflation likely snapped a four-month downward trend in May due to rapidly rising food costs

GSK seeks to appeal Delaware ruling allowing Zantac cases to go forward

The companies, which all sold Zantac at different times, argue that Medinilla should have granted their motion to block plaintiffs from presenting expert testimony that Zantac causes cancer

Indians get hooked on 10-minute grocery apps, squeezing small retailers

Swiggy warehouses are mushrooming across India to deliver everything from milk and bananas to condoms and roses within minutes - a business model that is reshaping how Indians shop

Apple's AI push may boost iPhone sales as customers look to upgrade

Facing choppy consumer spending and resurgent tech rivals, Apple has looked to AI as a way to invigorate its loyal fan base

White House close to naming Romero as FDIC head, replaces Martin Gruenberg

Goldsmith Romero, 53, has a background in enforcement and has led major actions against Wall Street banks and other financial firms during her career

China's central bank to resume gold buying as prices ease, say analysts

After adding to its gold reserves for 18 consecutive months, official data from the People's Bank of China (PBOC) showed its holdings were unchanged in May

Seoul activists develop 'smart balloons' to send messages into North Korea

Built using 3D printers and components sourced online and sometimes equipped with GPS-tracking, these so-called "smart balloons" can cost up to $1,000 each

Baltimore Port's key transit channel reopens following bridge collapse

Army Corps of Engineers said a survey on Monday certified the riverbed as safe for transit

US FDA grants accelerated approval to Genfit, Ipsen's liver disease drug

Ipsen added that standard approval for Iqirvo may be contingent on confirmatory trials